| PERIOD ENDING | 30-Jun-03 | 31-Mar-03 | 31-Dec-02 | 30-Sep-02 | | Total Revenue | 5,093 | 3,676 | 5,054 | 14,887 | | Cost of Revenue | 3,061 | 1,847 | 3,158 | 15,546 | | | Gross Profit | 2,032 | 1,829 | 1,896 | (659) | | | Operating Expenses | | Research Development | 1,108 | 876 | 1,153 | 4,805 | | Selling General and Administrative | 4,479 | 4,451 | 4,420 | 9,181 | | Non Recurring | (350) | 309 |
-
| 4,643 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,205) | (3,807) | (3,677) | (19,288) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 96 | | Earnings Before Interest And Taxes | (3,205) | (3,807) | (3,677) | (19,192) | | Interest Expense | 285 | 240 | 253 | 433 | | Income Before Tax | (3,490) | (4,047) | (3,930) | (19,625) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,490) | (4,047) | (3,930) | (19,625) | | | Non-recurring Events | | Discontinued Operations | (961) | (10,785) | (4,604) |
-
| | Extraordinary Items | 1,000 |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,451) | (14,832) | (8,534) | (19,625) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,451) | ($14,832) | ($8,534) | ($19,625) |
|
0.20% Nasdaq 
0.0001 (33.33%) 
Income Statement
